BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29975346)

  • 1. The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study.
    Mueller AM; Meier CR; Jick SS; Schneider C
    Pancreas; 2018 Aug; 47(7):807-815. PubMed ID: 29975346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study.
    Mueller AM; Meier CR; Jick SS; Schneider C
    Pancreatology; 2019 Jun; 19(4):578-586. PubMed ID: 30952448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer - a population-based nationwide case-control study.
    Sadr-Azodi O; Gudbjörnsdottir S; Ljung R
    Acta Oncol; 2015 Jul; 54(7):986-92. PubMed ID: 25734801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
    Lemanska A; Price CA; Jeffreys N; Byford R; Dambha-Miller H; Fan X; Hinton W; Otter S; Rice R; Stunt A; Whyte MB; Faithfull S; de Lusignan S
    PLoS One; 2022; 17(10):e0275369. PubMed ID: 36197912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study.
    Mamo Y; Bekele F; Nigussie T; Zewudie A
    BMC Endocr Disord; 2019 Aug; 19(1):91. PubMed ID: 31464602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose of behavioral weight loss treatment on glycemic control in adults with prediabetes.
    Bauman V; Ariel-Donges AH; Gordon EL; Daniels MJ; Xu D; Ross KM; Limacher MC; Perri MG
    BMJ Open Diabetes Res Care; 2019; 7(1):e000653. PubMed ID: 31245006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
    Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data.
    McAdam-Marx C; Mukherjee J; Bellows BK; Unni S; Ye X; Iloeje U; Brixner DI
    Diabetes Res Clin Pract; 2014 Mar; 103(3):402-11. PubMed ID: 24503045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.
    Wilding JPH; Rigney U; Blak BT; Nolan ST; Fenici P; Medina J
    Diabetes Res Clin Pract; 2019 Sep; 155():107791. PubMed ID: 31325543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
    Charlier S; Vavanikunnel J; Becker C; Jick SS; Meier C; Meier CR
    J Clin Endocrinol Metab; 2021 Jan; 106(2):554-566. PubMed ID: 33141149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus.
    Škrha P; Hořínek A; Pazourková E; Hajer J; Frič P; Škrha J; Anděl M
    Pancreatology; 2016; 16(5):839-43. PubMed ID: 27267055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer.
    Sohn SY; Lee EK; Han SS; Lee YJ; Hwangbo Y; Kang YH; Lee SD; Kim SH; Woo SM; Lee WJ; Hong EK; Park SJ
    Medicine (Baltimore); 2018 May; 97(18):e0590. PubMed ID: 29718860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms.
    Sandini M; Strobel O; Hank T; Lewosinska M; Nießen A; Hackert T; Büchler MW; Schimmack S
    Surgery; 2020 Mar; 167(3):575-580. PubMed ID: 31889543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts.
    Masuch A; Friedrich N; Roth J; Nauck M; Müller UA; Petersmann A
    BMC Endocr Disord; 2019 Feb; 19(1):20. PubMed ID: 30755204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.